HDV is a defective RNA pathogen requiring the simultaneous presence of HBV to complete its life cycle. Two major specific patterns of infection have been described: the coinfection with HDV and HBV of a susceptible, anti-HBs-negative individual, or the HDV superinfection of a chronic HBV carrier. Coinfection mostly leads to the eradication of both agents, whereas the majority of patients with HDV superinfection evolve to chronic HDV infection and hepatitis. Chronic HDV infection worsens the preexisting HBV-related liver damage. HDV-associated chronic liver disease (chronic hepatitis D) is characterized by necroinflammation and the relentless deposition of collagen culminating, within a few decades, into the development of cirrhosis and hepatocellular carcinoma. H epatitis D virus (HDV) infection characterizes a subgroup of hepatitis B surface antigen (HBsAg)-positive patients affected by a frequently aggressive form of chronic liver damage (hepatitis D). Because HDV particle assembly and release are dependent on the obligatory presence of HBV within the same hepatocytes, a productive HDV infection is invariably associated with HBV infection. Two major patterns of infection have been described: coinfection with HBV and HDV, or superinfection with HDV of a person chronically infected with HBV. A third minor pattern or helper-independent HDV infection has been reported in the liver transplant setting. Although its existence is questioned, it will be briefly discussed in view of its historical interest.
ACUTE HEPATITIS DAcute hepatitis D caused by HBV/HDV coinfection occurs on the simultaneous infection with both HBV and HDV of an individual who is susceptible to HBV (and therefore anti-HBs negative) (Fig. 1). From a clinical standpoint, this entity is indistinguishable from an acute hepatitis B (Smedile et al. 1982). Acute hepatitis D occurs after an incubation time of 1-2 mo. The preicteric phase is characterized by nonspecific symptoms such as fatigue, lethargy, digestive symptoms (anorexia, nausea), and the appearance of the usual biochemical markers, such as elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The icteric phase, which is not always observed,